Accessibility Help | Sitemap | Contact Us | Customer Support CALL 1-800-275-4524
United States Change Country
Careers | Investor Relations | News & Media | Events | KCI Recycling | About KCI
Home  |  Conditions  |  Products  |  Clinical Evidence  |  Education and Training  |  For Patients  |  Customer Support  |  Suppliers
You are here: Home > About KCI > News & Media > Media Inquiries
Print

News & Media

These press releases are intended as reference information for U.S. investors and journalists. The information contained in each press release was current at the time of issuance, and KCI assumes no responsibility for updating the information to reflect subsequent developments.

Top Stories

KCI, Leader in Advanced Wound Care Solutions KCI, LifeCell and Systagenix Combine to Form One Company and Rebrand as Acelity

Acelity is Industry Leading Medical Technology Company with $2 Billion in Revenue

KCI, Leader in Advanced Wound Care Solutions KCI Partners with B. Braun Medical to Sell Prontosan® Wound Irrigation Solution for Use with V.A.C. VeraFlo™ Negative Pressure Wound Therapy

Combination demonstrated a reduction in OR visits, length of stay and time to final surgical closure in recently published study

Headlines

Displaying 1 to 10 of 150 News Items
June 3rd 2014
New Study Reported Prevena™ Therapy Patients had a Significantly Lower Infection Rate Following Cardiac Surgery Compared to Control Group

Surgical incision management could generate savings of more than 60 million Euros in Germany alone

March 5th 2014
Independent Study Shows V.A.C. VeraFlo™ Therapy More Beneficial Than Traditional V.A.C.® Therapy

Study Found Statistically Significant Reductions in OR Visits and Hospital Stay vs. Traditional V.A.C.® Therapy

January 27th 2014
LifeCell Corporation Acquires Advanced Adipose Tissue Injector

Injector Offers Added Benefits to Surgeons and Patients and Expands the LifeCell Fat Grafting Portfolio

January 23rd 2014
KCI Earns New Innovative Technology Designation from Novation® for V.A.C.Ulta™ Therapy and Prevena™ Therapy

Significant designation only provided to a small portion of products on contract through Novation

January 14th 2014
KCI Negative Pressure Wound Therapy with Instillation Supplement Published in International Wound Journal

Supplement Based on Presentations from the 2012 and 2013 International Surgical Wound Forums

January 8th 2014
First International Consensus Guidelines Published for KCI Negative Pressure Wound Therapy with Instillation

Guidelines Published in Journal of Plastic and Reconstructive Surgery

November 21st 2013
KCI Introduces the Next Generation V.A.C.Via™ Therapy System

Portable System Provides Enhanced Features for Patients

Displaying 1 to 10 of 150 News Items

  • KCI Express
  • Share on Facebook.com
  • Share on Twitter
  • Visit our YouTube page

Important Message for Patients

Terms of Use | Privacy Policy | Contact Us | News Feed


Copyright © 1998 - 2013 KCI Licensing, Inc. All Rights Reserved.    DSL# 09-03-193
The information included in this Web site has been prepared for and is intended for viewing exclusively within the United States of America. This Web site contains information about products which may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please consult individual country sites for approved uses and any applicable restrictions.